Core Insights - The core point of the article is that Yijiahe (603666) has achieved a significant breakthrough in minimally invasive surgery with its subsidiary, Tadao Medical, receiving approval for its endoscopic surgical robot, which will be used in general surgery, urology, and gynecology [1] Group 1 - Yijiahe disclosed its investor activity record for July 2025 on August 4 [1] - Tadao Medical's endoscopic surgical robot has recently been approved for market launch [1] - The approval marks a major advancement for Tadao Medical in the minimally invasive surgery sector [1] Group 2 - Tadao Medical has obtained certification for several products, including endoscopic surgical robots, orthopedic surgical robots, two types of C-arm X-ray machines, puncture surgical robots, and a carbon fiber surgical table specifically for orthopedic robots [1]